Shokrollah Assar

Shokrollah Assar

Auto-generated profile, based on publicly available information

Shokrollah Assar

Immunology of Infectious Diseases Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2020 in Immunological Investigations
Verified
Journal Article
Closed access
SAShokrollah Assar
Shokrollah Assar
RNReza Nosratabadi
Reza Nosratabadi
HAHossein Khorramdel Azad
Hossein Khorramdel Azad
JMJavad Masoumi
Javad Masoumi
MMMahshad Mohamadi
Mahshad Mohamadi
GHGholamhossein Hassanshahi
Gholamhossein Hassanshahi
Past researches indicate that some types of antibiotics, apart from their antimicrobial effects, have some other important effects which indirectly are exerted by modulating and regulating the immune system’s mediators. Among the compounds with antimicrobial effects, fluoroquinolones (FQs) are known as synthetic antibiotics, which exhibit the property of decomposing of DNA and prevent bacterial growth by inactivating the enzymes involved in DNA twisting, including topoisomerase II (DNA gyrase) and IV. Interestingly, immune responses are indirectly modulated by FQs through suppressing pro-inflammatory cytokines, such as interleukin 1 (IL-1), IL-6, tumor necrosis factor-alpha (TNF-α), and super-inducing IL-2, which tend to increase both the growth and activity of T and B lymphocytes. In addition, they affect the development of immune responses by influencing of expression of other cytokines and mediators. This study aims to review past research on the immunomodulatory effects of FQs on the expression of cytokines, especially IL-2 and to discuss controversial investigations.

1 October 2016 in Cytokine
Verified
Journal Article
Closed access
MZMohammad Zare-Bidaki
Mohammad Zare-Bidaki
SAShokrollah Assar
Shokrollah Assar
HHHamid Hakimi
Hamid Hakimi
SASeyyed Hossein Abdollahi
Seyyed Hossein Abdollahi
RNReza Nosratabadi
Reza Nosratabadi
MAMohammad Kazemi Arababadi
Mohammad Kazemi Arababadi

8 January 2014 in Inflammation
Verified
Journal Article
Closed access
PDF file
HHHamid Hakimi
Hamid Hakimi
MZMohammad Zare-Bidaki
Mohammad Zare-Bidaki
NZNahid Zainodini
Nahid Zainodini
SAShokrollah Assar
Shokrollah Assar
MAMohammad Kazemi Arababadi
Mohammad Kazemi Arababadi

1 October 2014 in Asian Pacific Journal of Tropical Disease
Verified
Journal Article
Closed access
HYHassan Yousefidaredor
Hassan Yousefidaredor
MZMohammad Zare-Bidaki
Mohammad Zare-Bidaki
HHHamid Hakimi
Hamid Hakimi
SAShokrollah Assar
Shokrollah Assar
VBVahid Bagheri
Vahid Bagheri
MAMohammad Kazemi Arababadi
Mohammad Kazemi Arababadi

1 January 2012
Verified
Journal Article
Closed access
SAShokrollah Assar
Shokrollah Assar
MAMohammad Kazemi Arababadi
Mohammad Kazemi Arababadi
MMMaryam Mohit
Maryam Mohit
BABehzad Nasiri Ahmadabadi
Behzad Nasiri Ahmadabadi
PPPaul Pumpens
Paul Pumpens
DKDerek Kennedy
Derek Kennedy

1 January 2013 in Clinical Laboratory
Verified
Journal Article
Open access
SAShokrollah Assar
Shokrollah Assar
MAMohammad Kazemi Arababadi
Mohammad Kazemi Arababadi
BABehzad Nasiri Ahmadabadi
Behzad Nasiri Ahmadabadi
MSMansoor Salehi
Mansoor Salehi
DKDerek Kennedy
Derek Kennedy
Hepatitis B virus (HBV) is a serious risk as a disease that can be spread through blood transfusion. Occult hepatitis B infection (OBI) is defined in a patient with the presence of HBV-DNA but a lack of HBsAg in the serum and hepatocytes. OBI can be considered as a high potential risk factor for inducing post transfusion hepatitis (PTH), hepatocellular carcinoma (HCC), cirrhosis, and reactivation of the HBV. Recently, several investigations from various regions of the world have reported PTH as well as HCC and cirrhosis among blood recipients with diseases such as thalassemia and other disorders requiring regular hemodialysis. This form of hepatitis also causes complications for individuals that are co-infected with other viruses such as HCV and HIV. Because of its extreme disease potential, OBI can be considered a high risk for PTH, HCC, and cirrhosis. Therefore, an understanding of the prevalence of OBI among blood donors is a critical strategy in most transfusion services. This review addresses the recent information regarding the prevalence of OBI worldwide, with an additional focus on Iranian blood donors.Full Tex